Format

Send to

Choose Destination
Medicine (Baltimore). 2019 Sep;98(37):e17114. doi: 10.1097/MD.0000000000017114.

Clinical efficacy of weekly cisplatin for treatment of patients with breast cancer.

Author information

1
Department of Library, Mudanjiang Medical University.
2
Department of Urology.
3
Second Ward of Neurology Department, Affiliated Hongqi Hospital.
4
Institute of Neural Tissue Engineering.
5
Department of Anatomy, Mudanjiang Medical University, Mudanjiang, China.

Abstract

BACKGROUND:

We will investigate the efficacy and safety of weekly cisplatin (WC) for treatment of patients with breast cancer (BC) systematically.

METHODS:

This study will describe and critically appraise shared decision approaches used in randomized controlled trials of WC for treatment of patients with BC. We will comprehensively search the following databases: PubMed, EMBASE, Web of Science, Cochrane Library, CINAHL, PsycINFO, Allied and Complementary Medicine Database, Wanfang, and Chinese Biomedical Literature Database from inception through July 1, 2019. We will utilize RevMan V.5.3 software (London, UK) for statistical analysis.

RESULTS:

This study will systematically explore the efficacy and safety of WC for the treatment of patients with BC through evaluating primary outcomes of overall survival, pathological complete response; and secondary outcomes of cancer-specific survival, recurrence-free survival, disease-free survival, quality of life, and toxicities.

CONCLUSION:

This study will provide latest evidence of WC for the treatment of patients with BC.

SYSTEMATIC REVIEW REGISTRATION:

PROSPERO CRD42019145358.

PMID:
31517847
DOI:
10.1097/MD.0000000000017114
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center